Faculty Opinions recommendation of Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis - a double-blind comparison with sustained release mesalazine.

Herbal Extract ◽

Double Blind ◽

Blind Comparison

Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis - a double-blind comparison with sustained release mesalazine

10.1111/j.1365-2036.2010.04515.x ◽

2010 ◽

Vol 33 (2) ◽

pp. 194-202 ◽

Cited By ~ 57

Author(s):

T. Tang ◽

S. R. Targan ◽

Z.-S. Li ◽

C. Xu ◽

V. S. Byers ◽

...

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

Sustained Release ◽

Herbal Extract ◽

Double Blind ◽

Blind Comparison

Randomised clinical trial: Efficacy and safety of Qing-Chang-Hua-Shi granules in a multicenter, randomized, and double-blind clinical trial of patients with moderately active ulcerative colitis

Biomedicine & Pharmacotherapy ◽

10.1016/j.biopha.2021.111580 ◽

2021 ◽

Vol 139 ◽

pp. 111580

Author(s):

Hong Shen ◽

Shengsheng Zhang ◽

Wenxia Zhao ◽

Shunping Ren ◽

Xiao Ke ◽

...

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Clinical Trial

Randomised clinical trial: early assessment after 2weeks of high-dose mesalazine for moderately active ulcerative colitis - new light on a familiar question

Yearbook of Medicine ◽

10.1016/s0084-3873(11)00325-7 ◽

2011 ◽

Vol 2011 ◽

pp. 450-451

Author(s):

M.F. Picco

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

High Dose ◽

Early Assessment

Faculty of 1000 evaluation for Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718030851.793482493 ◽

2013 ◽

Author(s):

Joanne Jordan ◽

Amanda Nelson

Keyword(s):

Clinical Trial ◽

Sustained Release ◽

Hip Osteoarthritis ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

Parallel Group

A double-blind comparison of balsalazide, 6.75 g daily, and sulfasalazine, 3 g daily, in patients with newly diagnosed or relapsed active ulcerative colitis

10.1046/j.1365-2036.2002.01150.x ◽

2002 ◽

Vol 16 (1) ◽

pp. 61-68 ◽

Cited By ~ 55

Author(s):

J. R. B. Green ◽

J. C. Mansfield ◽

J. A. Gibson ◽

G. D. Kerr ◽

P. C. Thornton

Keyword(s):

Ulcerative Colitis ◽

Newly Diagnosed ◽

Double Blind ◽

Blind Comparison

Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis

10.1111/apt.12266 ◽

2013 ◽

Vol 37 (8) ◽

pp. 767-775 ◽

Cited By ~ 36

Author(s):

B. Flourié ◽

H. Hagège ◽

G. Tucat ◽

D. Maetz ◽

X. Hébuterne ◽

...

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

Prolonged Release ◽

Active Ulcerative Colitis

Randomised clinical trial: a herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis - a double-blind, double-dummy study

10.1111/apt.12397 ◽

2013 ◽

Vol 38 (5) ◽

pp. 490-500 ◽

Cited By ~ 42

Author(s):

J. Langhorst ◽

I. Varnhagen ◽

S. B. Schneider ◽

U. Albrecht ◽

A. Rueffer ◽

...

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

Herbal Preparation ◽

Double Blind

Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: A double-blind randomized placebo controlled clinical trial

Journal of Crohn s and Colitis ◽

10.1016/j.crohns.2014.06.001 ◽

2014 ◽

Vol 8 (11) ◽

pp. 1498-1505 ◽

Cited By ~ 50

Author(s):

Andreas Munk Petersen ◽

Hengameh Mirsepasi ◽

Sofie Ingdam Halkjær ◽

Esben Munk Mortensen ◽

Inge Nordgaard-Lassen ◽

...

Keyword(s):

Escherichia Coli ◽

Ulcerative Colitis ◽

Clinical Trial ◽

Controlled Clinical Trial ◽

Double Blind ◽

Escherichia Coli Nissle

Clinical trial: a multicentre, randomized, double-blind, placebo-controlled, dose-finding, phase II study of subcutaneous interferon-β-1a in moderately active ulcerative colitis

10.1111/j.1365-2036.2008.03778.x ◽

2008 ◽

Vol 28 (6) ◽

pp. 758-767 ◽

Cited By ~ 24

Author(s):

C. PENA-ROSSI ◽

S. SCHREIBER ◽

G. GOLUBOVIC ◽

A. MERTZ-NIELSEN ◽

J. PANES ◽

...

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

Phase Ii ◽

Phase Ii Study ◽

Dose Finding ◽

Interferon Β ◽

Double Blind ◽

Double Blind Placebo

Faculty Opinions recommendation of Randomised clinical trial: a herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis--a double-blind, double-dummy study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718026783.793483711 ◽

2013 ◽

Author(s):

Ivano Biviano

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

Herbal Preparation ◽

Double Blind